The company usually posts poor financials for mid or long term investments.
For a short-term investment strategy, the company has poor fundamentals.
Strengths
Over the last seven days, analysts have been revising upwards their EPS estimates for the company.
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
Within the weekly time frame the stock shows a bullish technical configuration above the support level at 9.22 USD
Weaknesses
Stock prices approach a strong long-term resistance in weekly data at USD 14.
Technically, the stock approaches a strong medium-term resistance at USD 14.97.
Low profitability weakens the company.
The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
For the past year, analysts have significantly revised downwards their profit estimates.